Online Submissions

Already have a Username/Password for Einstein Journal of Biology and Medicine?
Go to Login


Author Guidelines

Manuscript Requirements

Format. Files should be submitted as Microsoft Word (.doc or .docx) documents. All four margins in manuscripts should be one (1) inch. Manuscripts should use Times New Roman, 11pt and should be double spaced. 

Required Sections. All manuscripts should be arranged in the following order, with each item beginning a new page: 1) title page, 2) abstract (where applicable), 3) text, 4) references, and 5) tables and/or figures. All pages must be numbered.

Title Page. All manuscripts should include a Title Page. Title pages should include the following information: 

  1. Title: The title should be informative, declarative, and as brief as possible. 
  2. Byline: The name, department, institution, mailing address, academic degrees, and e-mail for each author should be furnished. Authors' full names should be provided. If there are several authors with different affiliations, authors should be matched to their respective departments or institutions by means of numerical superscripts after the authors’ names. If an author has moved since doing the work described, indicate the institution at which the work was done in the primary affiliation listing and use an additional superscript to indicate the present address.
  3. Corresponding Author: Include a full mailing address and e-mail address for the author who is to serve as the corresponding author.
  4. Previous Presentation: If the paper was presented at a meeting, give the name of the meeting, the location, and date.
  5. Conflict of Interest: Any commercial, financial, or other involvements within the past year that might present a conflict of interest in connection with the submitted article (e.g. including but not limited to institutional or corporate affiliations, paid consultancies, stock ownership or other equity interests, patent ownership, royalties, funds for travel, and interests in patents, instruments, and technologies) must be acknowledged. 
  6. Acknowledgments: Collegiate acknowledgments should precede those for grant support. Grant support should include the full name of the granting agency and grant number. This includes, but is not limited to, all federal or private funding used to support authors or the research, all grants to students (research or fellowship grants), and any other potential sources of support or funding. Corporate support of any kind must be acknowledged.
  7. Author Contributions: Information regarding author contributions should be provided, as applicable. Note the authors: responsible for study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript, statistical analysis, and key administrative, technical, or material support.
  8. Keywords, Word Count, Tables and Figures: Include five words or phrases that summarize the major topics covered by the manuscript. Include the number of words excluding the abstract, tables, figures, references, and online-only material. Include the number of figures and tables.

 Abstract. Structured abstracts should not exceed 300 words and should contain 5 sections: objectives, background, methods, results, and conclusions. Unstructured abstracts should not exceed 200 words, except for Case Report abstracts which should not exceed 100 words. The abstract should clearly state the subject and main conclusions of the manuscript, and it should avoid the use of abbreviations and unfamiliar or new terminology.

Study Methods. A manuscript presenting original data from patient populations should provide a comprehensive description of the nature of the study group, methods for recruitment, measurement, and evaluation techniques (including reliability), and data analysis. At the end of the section describing the subjects it should be clearly stated what type of informed consent was obtained. Studies that require Institutional Review Board (IRB) approval must note which IRB granted approval. Strengths and weaknesses of the study should be presented in the discussion.

Data analysis. Adequate description of statistical analyses should be provided, including the names of the statistical tests and whether tests were one-or two-tailed. Standard deviations, rather than standard errors of the mean, are required. Statistical tests that are not well-known should be referenced. All significant and important nonsignificant results must include the test value, all degrees of freedom, and probability. For example, "The analysis of variance indicated that those who abstained from coffee had significantly higher course grades than those who did not abstain (F = 4.32, df = 3, 17, p < 0.05)." Reviewers will evaluate the appropriateness of the analyses. Abbreviations and symbols. The Einstein Journal of Biology and Medicine distinguishes between standard and non-standard abbreviations. Standard abbreviations for units of measure do not need to be defined. Other abbreviations are considered non-standard and must be spelled out upon first usage. Non-standard abbreviations should be used only for terms mentioned five or more times in the paper. Both standard and non-standard abbreviations should also conform to international standards. Authors should refer to: IUPAC Manual of Symbols and Terminology for Physicochemical Quantities and Units or Guide for the Use of the International System of Units (SI). 

Drugs. Generic names should be used. Brand names may be inserted in parentheses following the generic name and used thereafter as the major identifier. 

Foonotes. Footnotes for text are not acceptable within the text of articles submitted, except for tables and figures.

References. As of October 2012 EJBM employs the APA 6th edition “Author-Date” citation style. References should be restricted to pertinent material. Authors are responsible for the accuracy and completeness of their citations. The Editors will not revise references. EJBM strongly encourages use of the bibliography program Endnote ( to ensure proper formatting of citations. All references should be listed, without numbers, in alphabetical order at the end of the article. List all authors; do not use "et al." Abbreviations of journal names should conform to the style used by PubMed. Personal communications, unpublished manuscripts, manuscripts submitted but not yet accepted, and similar unpublished items should appear in the reference list as "personal communication," "in preparation," "submitted for publication," accordingly, without mention of a journal. It is the author's responsibility to obtain permission to refer to another individual's unpublished observations. Manuscripts that are actually "in press" may be cited as such in the reference list; the name of the journal or publisher and location must be included. If the author of a document is not identified, begin the reference with the title of the document. If the publication date of a document is not identified, indicate “no date” in place of the date.

Tables. Tables must be self-explanatory, and each table should be provided on a separate page. In addition, table titles labeled with Arabic numerals, legends, and footnotes should be provided on a separate page. Tables that duplicate material contained elsewhere in the manuscript (i.e. in text, figures, or other tables) should not be used. Authors should delete short tables containing data that could be given succinctly in text. EJBM does not publish tabulated data that have been submitted elsewhere or previously published. Nonstandard abbreviations should be used sparingly and must be defined in the legend at the bottom of the table, if not defined earlier in the text. Each vertical column requires a heading. Reference to footnotes should be made by means of lower case letters (a, b, c, etc.). Scales with large or small numbers should use numbers multiplied by powers of 10. 

Figures. All figures should be appended to the end of the document. EJBM encourages the submission of high-quality figures (e.g. photographs, illustrations, charts, and graphs). High resolution images will be required if the manuscript is accepted. Each complete figure (including titles and footnotes) should be understandable without reference to the text. Figures should represent data visually rather than numerically. It is particularly important that nomenclature, abbreviations, and units used in figures agree precisely with those used in the text of the paper. A composite figure carries a single figure number; upper case letters identify the individual parts. Photographs should be cropped to the final intended width. It is preferable for magnifications to be shown by means of a bar on the photograph as well as a number in the legend. Where necessary, the orientation for the illustration should be indicated by an arrow and the word “top.” Scales with large or small numbers should use numbers multiplied by powers of 10. If figures have been previously published, the author must secure written permission from the holder of copyright for republication in the EJBM as well as the right and license to further republish and reproduce in any language, format, or media (including print, electronic, or other media), distribute reproductions, adapt, and display such figures, as well as the right to sublicense any or all of the foregoing. The author should submit a copy of the permission release and credit lines if the manuscript is accepted for publication. 


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
  7. As an author of this manuscript, I certify that all forms of support, including drug company support, are acknowledged; any commercial or financial involvements within the past year that might present an appearance of a conflict of interest in connection with the submitted article (e.g., potential conflicts include but are not limited to institutional or corporate affiliations, paid consultancies, stock ownership or other equity interests, patent ownership, royalties, funds for travel, and interests in patents, instruments, and technologies) are disclosed in the cover letter. If the article is accepted for publication, I will consult with the Editor on whether, and to what extent, this information should be included in the published article. In addition, I have not signed an agreement with any sponsor of the study reported in this article that has a clause which prevents me from publishing both positive and negative results, from collaborating with other investigators to pool data across sites, or that forbids me from publishing without the approval of the sponsor.

Copyright Notice

As an author of this manuscript, I either 1) approve the submission of this work and all subsequent revisions for publication and transfer, assign, or otherwise convey all copyright ownership to the work in whole, in part, in abridged format, and materials contained in the work and grant the right and license to publish, republish, and reproduce in any language, format, or media (including without limitation, print, electronic, or any other media) distribute reproductions, adapt, publicly perform, and display the work, the material in the work, or any part there of, as well as the right to sublicense any or all of the foregoing to The Einstein Journal of Biology and Medicine or 2) the work described in this paper was done as part of my employment with the federal government and is therefore in the public domain. I warrant that this work represents original material and does not infringe upon the copyright of any third party; that no part of the work has been published or will be submitted for publication elsewhere in any language or format unless and until it is rejected by The Einstein Journal of Biology and Medicine; that to the best of my knowledge, the work contains no libelous or unlawful matter; and permission from publishers and copyright holders has been obtained, including the right and license to use, publish, republish, and reproduce in any language, format, or media (including without limitation, print, electronic, and any other media), distribute reproductions, adapt, publicly perform, and display extensive quotations (i.e., more than 500 words) or figures that have been previously published or submitted elsewhere, as well as the right to sublicense any or all of the foregoing. I agree to indemnify The Einstein Journal of Biology and Medicine, the Albert Einstein College of Medicine, and Yeshiva University against any loss or damages arising out of a breach of this agreement. Any author may reserve the right to use all or part of this manuscript for future works of their own by obtaining written permission from The Einstein Journal of Biology and Medicine. In addition, the right to grant or refuse republication or distribution of this manuscript by third parties is reserved by The Einstein Journal of Biology and Medicine. In the event that this submission is not published, copyright ownership shall revert to the authors.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.